F A Sirgel
- Infectious Diseases top 2%
- Epidemiology top 5%
- Surgery
- Molecular Biology
- Pharmacology top 10%
- Co-authors
- Peter R. DonaldPaul D. van HeldenRoxana RustomjeeD. P. ParkinB. W. Van de WalD A MitchisonAmour VenterD.A. Mitchison
- Topics
- Tuberculosis Research and Epidemiology (16 papers)Mycobacterium research and diagnosis (11 papers)Pneumonia and Respiratory Infections (5 papers)
- Journals
- PLoS ONEAmerican Journal of Respiratory and Critical Care MedicineClinical Infectious Diseases
- Partner nations
- South AfricaUnited KingdomUnited States
In The Last Decade
F A Sirgel
18 papers receiving 811 citations
Peers
Comparison fields: 5 of 59
- Infectious Diseases 725
- Epidemiology 591
- Surgery 255
- Molecular Biology 181
- Pharmacology 121
Countries citing papers authored by F A Sirgel
This map shows the geographic impact of F A Sirgel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F A Sirgel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F A Sirgel more than expected).
Fields of papers citing papers by F A Sirgel
This network shows the impact of papers produced by F A Sirgel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F A Sirgel. The network helps show where F A Sirgel may publish in the future.
Co-authorship network of co-authors of F A Sirgel
This figure shows the co-authorship network connecting the top 25 collaborators of F A Sirgel. A scholar is included among the top collaborators of F A Sirgel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F A Sirgel. F A Sirgel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 17 | |
| 3 | 26 | |
| 4 | 29 | |
| 5 | A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. | 230 |
| 6 | 83 | |
| 7 | 4 | |
| 8 | 69 | |
| 9 | 51 | |
| 10 | 25 | |
| 11 | 89 | |
| 12 | Primary drug-resistant tuberculosis in children. | 53 |
| 13 | 31 | |
| 14 | 36 | |
| 15 | Rifampicin resistance in Mycobacterium tuberculosis--rapid detection and implications in chemotherapy. | 10 |
| 16 | Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis. | 43 |
| 17 | 2 | |
| 18 | 47 | |
| 19 | 4 |
About F A Sirgel
F A Sirgel is a scholar working on Infectious Diseases, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 19 papers that have together received 849 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (11 papers) and Pneumonia and Respiratory Infections (5 papers). The work is most often cited by research in Infectious Diseases (725 citations), Molecular Medicine (113 citations) and Epidemiology (591 citations). F A Sirgel has collaborated with scholars based in South Africa, United Kingdom and United States. Frequent co-authors include Peter R. Donald, Paul D. van Helden, Roxana Rustomjee, D. P. Parkin, B. W. Van de Wal, D A Mitchison, Amour Venter, D.A. Mitchison, Thomas P. Kanyok and J. S. Maritz. Their work appears in journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.